TY - JOUR AU - Pita Calandre, Elena AU - Hidalgo Tallon, Javier AU - Molina-Barea, Rocío AU - Rico-Villademoros, Fernando AU - Molina Hidalgo, Cristina AU - García-Leiva, Juan Miguel AU - Carrillo Izquierdo, Antonio AU - Slim, Mahmoud PY - 2021 UR - http://hdl.handle.net/10481/71293 AB - Background: Gastrointestinal symptomatology is frequent among patients with fibromyalgia, which increases disease burden and lacks specific treatment, either pharmacological or nonpharmacological. We aimed to evaluate the efficacy and tolerability of... LA - eng PB - MDPI KW - Fibromyalgia KW - Gastrointestinal symptoms KW - Probiotics KW - VSL#3® KW - Efficacy KW - Tolerability TI - The Probiotic VSL#3 Does Not Seem to Be Efficacious for the Treatment of Gastrointestinal Symptomatology of Patients with Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial DO - 10.3390/ph14101063 ER -